Skye Bioscience
SKYE
SKYE
57 hedge funds and large institutions have $85.3M invested in Skye Bioscience in 2025 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
-18
Holders Change %
-24%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
12
Increased
13
Reduced
16
Closed
29
Calls
$388K
Puts
$184K
Net Calls
+$204K
Net Calls Change
+$141K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.97M |
| 2 |
FAM
Fred Alger Management
New York
|
+$842K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$436K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$218K |
| 5 |
Two Sigma Investments
New York
|
+$195K |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.92M |
| 2 |
BlackRock
New York
|
-$3.3M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.17M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$1.31M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.27M |
